- Home
- WIA vs SCPH Comparison
WIA vs SCPH Comparison
Compare WIA & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WIA
- SCPH
- Stock Information
- Founded
- WIA 2003
- SCPH 2013
- Country
- WIA United States
- SCPH United States
- Employees
- WIA N/A
- SCPH N/A
- Industry
- WIA Trusts Except Educational Religious and Charitable
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- WIA Finance
- SCPH Health Care
- Exchange
- WIA Nasdaq
- SCPH Nasdaq
- Market Cap
- WIA 196.4M
- SCPH 299.0M
- IPO Year
- WIA N/A
- SCPH 2017
- Fundamental
- Price
- WIA $8.43
- SCPH $5.61
- Analyst Decision
- WIA
- SCPH Buy
- Analyst Count
- WIA 0
- SCPH 3
- Target Price
- WIA N/A
- SCPH $12.00
- AVG Volume (30 Days)
- WIA 39.2K
- SCPH 2.3M
- Earning Date
- WIA 01-01-0001
- SCPH 11-12-2025
- Dividend Yield
- WIA 12.29%
- SCPH N/A
- EPS Growth
- WIA N/A
- SCPH N/A
- EPS
- WIA N/A
- SCPH N/A
- Revenue
- WIA N/A
- SCPH $49,969,000.00
- Revenue This Year
- WIA N/A
- SCPH $108.95
- Revenue Next Year
- WIA N/A
- SCPH $78.30
- P/E Ratio
- WIA N/A
- SCPH N/A
- Revenue Growth
- WIA N/A
- SCPH 107.79
- 52 Week Low
- WIA $7.56
- SCPH $1.94
- 52 Week High
- WIA $8.91
- SCPH $6.28
- Technical
- Relative Strength Index (RSI)
- WIA 55.42
- SCPH 63.30
- Support Level
- WIA $8.25
- SCPH $4.33
- Resistance Level
- WIA $8.45
- SCPH $5.62
- Average True Range (ATR)
- WIA 0.06
- SCPH 0.04
- MACD
- WIA 0.00
- SCPH 0.00
- Stochastic Oscillator
- WIA 72.12
- SCPH 78.57
About WIA Western Asset Inflation-Linked Income Fund
Western Asset Inflation Linked Income Fund is a diversified, closed-end management investment company. The primary investment objective of the group is to provide current income while its secondary investment objective is capital appreciation. Under normal market conditions and at the time of purchase, the Fund will invest at least 80% of its total managed assets in inflation-linked securities and at least 60% of its total managed assets in U.S. Treasury Inflation Protected Securities (TIPS). The Fund may also invest up to 40% of its total managed assets in non-U.S. dollar investments.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.